Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-16T16:41:48.397Z Has data issue: false hasContentIssue false
  • English
  • Français

Dread Disease Cover—An Actuarial Perspective

Published online by Cambridge University Press:  11 August 2014

A. C. Dash  and
D. L. Grimshaw
Get access

Extract

A Dread Disease contract pays out a lump sum on the diagnosis of any of a number of specified diseases. Those most commonly covered are heart attack, coronary artery disease requiring surgery, cancer and stroke. The benefit can take either of two main forms—it may provide an acceleration of all or part of any death benefit or it may be an additional benefit. It can be sold in conjunction with many conventional products or as a stand-alone policy.

Dread Disease contracts were originally developed in South Africa in the early 1980's, although cancer riders had previously been sold in the U.S.A., Japan and Israel. To some extent the marketing of these contracts was insensitive and preyed on people's fears in a distasteful way. This may explain some initial reluctance amongst U.K. insurers to enter this market; however with marketing literature now emphasizing more positive aspects, this appears to have been overcome.

Type
Research Article
Information
Journal of the Staple Inn Actuarial Society , Volume 33 , Issue 1 , 1993 , pp. 149 - 193
Copyright
Copyright © Staple Inn Actuarial Society 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

(1) Cancer Statistics: Registrations 1983. OPCS Series MB1 no. 15, HMSO.Google Scholar
(2) Morbidity Statistics from General Practice 1981–2. RCGP, OPCS, DHSS Series MB5 no. 1, HMSO.Google Scholar
(3) Cancer Survival 1981 registrations. OPCS Monitor MB1 88/1, HMSO.Google Scholar
(4) Singer, R. B. and Levinson, L. (Eds) (1976) Medical Risks: Patterns of Mortality and Survival. Lexington Books.Google Scholar
(5) Haberman, S. (1983) ‘Scientific Underwriting: “Stroke” as a model.’ J.I.A., 110, 445.Google Scholar
(6) Mortality Statistics by Cause 1985. OPCS Series DH2, no. 12, HMSO.Google Scholar
(7) Mortality in 1979–82 according to Cause of Death (1988). CMI Report no. 9.Google Scholar
(8) Cause of Disability: Individual P.H.I. Policies 1975–78 (1986). CMI Report no. 8.Google Scholar
(9) Smoking and Health, a report of the Surgeon General (1979). U.S. Department of Health, Education and Welfare.Google Scholar
(10) Medical Impairment Study (1983). Society of Actuaries and Association of Life Insurance Medical Directors of America.Google Scholar
(11) Marasca, G. and McEvoy, M. (1986). ‘Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom’, British Medical Journal, 292.CrossRefGoogle ScholarPubMed
(12) Morbidity Statistics from General Practice 1970–71, Socio-Economic Analyses. RCGP, OPCS, DHSS Studies on Medical and Population Subjects no. 46, HMSO.Google Scholar
(13) 1987 World Health Statistics Annual. WHO.Google Scholar
(14) World Health Organization Weekly Epidemiological Record WHO. 7th April 1989.Google Scholar